Idiopathic giant cell myocarditis and cardiac sarcoidosis

Lori A Blauwet1, Leslie T Cooper

  • 1Division of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA, blauwet.lori@mayo.edu.

Heart Failure Reviews
|November 1, 2012
PubMed

Insights

Idiopathic giant cell myocarditis (GCM) and cardiac sarcoidosis (CS) are rare, progressive heart conditions. Early diagnosis via myocardial tissue and imaging is crucial for tailored immunosuppressive treatment and improved patient outcomes.

Area of Science:

  • Cardiology
  • Immunology
  • Pathology

Background:

  • Idiopathic giant cell myocarditis (GCM) and cardiac sarcoidosis (CS) are uncommon causes of cardiomyopathy.
  • These conditions often present with ventricular arrhythmias or heart block.
  • Their etiology is complex, potentially involving infection, autoimmune factors, and genetics.

Purpose of the Study:

  • To highlight the diagnostic challenges and therapeutic importance of GCM and CS.
  • To emphasize the need for early and accurate diagnosis of these rare cardiac disorders.
  • To underscore the role of immunosuppressive therapy in altering the clinical course.

Main Methods:

  • Review of existing literature on GCM and CS.
  • Discussion of diagnostic approaches, including myocardial tissue analysis and noninvasive imaging.
  • Analysis of treatment strategies and prognostic factors.

Main Results:

  • GCM and CS are typically progressive despite standard therapies.
  • Initial clinical diagnosis is often difficult, necessitating myocardial biopsy.
  • Noninvasive imaging modalities can assist in diagnosis and monitoring treatment response.

Conclusions:

  • Early diagnosis of GCM and CS is critical for effective management.
  • Tailored immunosuppressive treatment can significantly impact the clinical trajectory.
  • Prognosis for GCM is generally poor, while CS prognosis depends on left ventricular function.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...